Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCytek BioSciences Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2026 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2026 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q4 2026 | 1 | -$0.00 | -$0.00 | -$0.00 |
| Q1 2027 | 1 | -$0.07 | -$0.06 | -$0.07 |
| Q2 2027 | 1 | -$0.04 | -$0.03 | -$0.04 |
| Q3 2027 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2027 | 1 | $0.02 | $0.03 | $0.03 |
| Q1 2028 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2028 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2028 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q4 2028 | 1 | $0.01 | $0.01 | $0.01 |
Cytek BioSciences Inc Earnings Date And Information
Cytek BioSciences Inc last posted its earnings results on Wednesday, November 5th, 2025. The company reported $-0.01 earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by $0.02. The company had revenue of 52.29 M for the quarter and had revenue of 200.45 M for the year. Cytek BioSciences Inc has generated $0 earnings per share over the last year ($-0.0461 diluted earnings per share) and currently has a price-to-earnings ratio of -108.08. Cytek BioSciences Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 4th, 2026 based on prior year's report dates.
Cytek BioSciences Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2025 | Q3 2025 | $0.01 | -$0.04 | -0.05 | $51.21 M | $52.29 M |
| 08/06/2025 | Q2 2025 | -$0.02 | -$0.04 | -0.02 | $46.34 M | $45.60 M |
| 05/08/2025 | Q1 2025 | -$0.04 | -$0.09 | -0.05 | N/A | $41.46 M |
| 02/27/2025 | Q4 2024 | N/A | $0.07 | N/A | N/A | $57.48 M |
| 11/06/2024 | Q3 2024 | N/A | $0.01 | N/A | $50.70 M | $51.50 M |
| 08/06/2024 | Q2 2024 | -$0.03 | -$0.08 | -0.05 | $49.53 M | $46.62 M |
| 05/08/2024 | Q1 2024 | -$0.05 | -$0.05 | 0 | N/A | $44.86 M |
| 03/13/2024 | Q4 2023 | $0.03 | $0.04 | 0.01 | N/A | $58.23 M |
| 11/14/2023 | Q3 2023 | N/A | -$0.05 | N/A | N/A | $48.00 M |
| 08/08/2023 | Q2 2023 | -$0.01 | -$0.03 | -0.02 | N/A | $49.69 M |
| 05/09/2023 | Q1 2023 | -$0.02 | -$0.05 | -0.04 | N/A | $37.09 M |
| 03/01/2023 | Q4 2022 | N/A | $0.03 | N/A | N/A | $48.34 M |
| 11/09/2022 | Q3 2022 | $0.02 | $0.01 | -0.01 | N/A | $40.48 M |
| 08/10/2022 | Q2 2022 | $0.02 | -$0.00 | -0.02 | N/A | $40.16 M |
| 05/11/2022 | Q1 2022 | N/A | -$0.02 | N/A | N/A | $35.06 M |
| 03/17/2022 | Q4 2021 | N/A | $0.00 | N/A | N/A | $38.89 M |
| 11/12/2021 | Q3 2021 | N/A | $0.01 | N/A | N/A | $34.38 M |
| 09/02/2021 | Q2 2021 | N/A | $0.02 | N/A | N/A | $30.41 M |
| 03/30/2021 | Q1 2021 | N/A | $0.00 | N/A | N/A | $24.27 M |
| 12/30/2020 | Q4 2020 | N/A | $0.05 | N/A | N/A | $30.62 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cytek BioSciences Inc Earnings: FAQ's
Cytek BioSciences Inc has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 4th, 2026 based offlast year's report dates.
The conference call for Cytek BioSciences Inc's latest earnings report can be listened to online.
The conference call transcript for Cytek BioSciences Inc's latest earnings report can be read online.
Cytek BioSciences Inc (:CTKB) has a recorded annual revenue of $200.45 M.
Cytek BioSciences Inc (:CTKB) has a recorded net income of $-6,020,000.Cytek BioSciences Inc has generated $-0.046 earnings per share over the last four quarters.
Cytek BioSciences Inc (:CTKB) has a price-to-earnings ratio of -108.08 and price/earnings-to-growth ratio is -2.43.